Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies are emerging a technologically advanced ... Read more
Bispecific antibodies are antibodies that have binding sites for two different antigens or epitopes. They combine two monospecific antibodies together in one molecule to redirect immune cells to tumor sites. Bispecific antibodies allow for highly targeted delivery of immune effector cells to tumor sites, promising more efficacious treatment options with improved safety profiles over existing targeted therapies.
The global Bispecific Antibodies Market is estimated to be valued at US$ ... Read more
The bispecific antibodies market involves therapeutic antibodies that can bind to two different antigens simultaneously. Bispecific antibodies are engineered to bring a patient's own immune cells closer to tumor cells, helping overcome tumor evasion of the immune system. The dual binding properties enable these antibodies to recognize and attack cancer cells more effectively.
